XML 115 R49.htm IDEA: XBRL DOCUMENT

Note 19 - Segment and Geographic Information (Tables)

12 Months Ended

May 31, 2014

Schedule of Segment Reporting Information, by Segment [Table Text Block]

					Successor		Predecessor
					August 20, 2011		June 1, 2011
	Year Ended				through		through
	May 31, 2014		May 31, 2013		May 31, 2012		August 19, 2011
Net sales by product group:
Transfusion	$	330,547		330,931		257,046		73,632
Transplant & Molecular		57,509		16,857		4,768		1,278
Total	$	388,056		347,788		261,814		74,910

Revenue from External Customers by Products and Services [Table Text Block]

					Successor		Predecessor
					August 20, 2011		June 1, 2011
	Year Ended				through		through
	May 31, 2014		May 31, 2013		May 31, 2012		August 19, 2011
Net sales to customers by geography are as follows:
United States	$	239,204		229,944		173,918		50,988
Europe (A)		79,219		63,643		49,486		14,180
Canada		19,127		19,985		14,349		3,907
Other		50,506		34,216		24,061		5,835
Total	$	388,056		347,788		261,814		74,910

Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]

	As of May 31
	2014		2013
Long-lived assets (excluding goodwill and intangibles) by geography:
United States	$	54,066		57,184
Europe (B)		15,725		13,399
Canada		4,517		4,511
Other (C)		2,003		1,287
Total	$	76,311		76,381

	As of May 31
	2014		2013
Concentration of net assets by geography:
United States	$	299,948		485,968
Europe		123,095		114,740
Canada		32,802		32,910
Other (C)		12,771		11,088
Total	$	468,616		644,706

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details